REGN

$614.73 -0.07% $-0.45
Jun 16, 2026 04:00 AM

Regeneron is a biotechnology company that discovers, develops, and manufactures innovative medicines for serious diseases.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Jun 17, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Advance Your REGN Trading Now

Take control of your trading with OHLCX. Our platform offers unparalleled analysis and technical support for REGN, designed to enhance your market performance. Transform your trading strategy now and experience the difference with our expert tools!

Boost Performance Now

Frequently Asked Questions

Regeneron developed monoclonal antibody treatments for COVID-19, which have been authorized for emergency use.

You can invest in Regeneron by purchasing shares through a brokerage account or investing in funds that include REGN stock.

Yes, Regeneron is publicly traded on the NASDAQ under the ticker symbol REGN.

As a biotech company, Regeneron focuses on the development of drugs that are often targeted therapies for complex diseases.

Regeneron conducts extensive clinical trials to test the safety and efficacy of its drugs before seeking regulatory approval.

Regeneron invests heavily in research and development, with a focus on genetic and molecular medicine to treat serious diseases.

More information can be found on Regeneron’s official website, in investor relations sections, and through financial news sources.

Regeneron works with healthcare providers and payers to ensure its medications are accessible and affordable.

Regeneron utilizes its proprietary VelociSuite technologies to develop new therapeutic candidates efficiently.

Regeneron was founded in 1988 and has since become a leader in biotechnology and pharmaceutical innovation.

Empower Your REGN Trading Now

Discover unparalleled trading insights with OHLCX Platform. Our automated system offers advanced analysis and technical indicators for REGN, aimed at optimizing your trading decisions. Enhance your market performance today and get ahead in the market now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.